Navigation Links
Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes
Date:2/10/2009

HAYWARD, Calif., Feb. 10 /PRNewswire/ -- Arete Therapeutics Inc. today announced the initiation of a Phase IIa clinical trial for AR9281, an orally- administered soluble epoxide hydrolase (s-EH) inhibitor being developed for the treatment of type 2 diabetes. S-EH is an enzyme involved in the metabolism of arachidonic acid, a key signaling molecule implicated in diabetes, hypertension and inflammatory disorders.

"Our AR9281 Phase II clinical trial program breaks new ground in two key areas. This is the first clinical study of a s-EH inhibitor in patients, and the first study designed to establish proof of concept that s-EH inhibition modulates glucose metabolism or blood pressure in patients with impaired glucose tolerance and hypertension," said James Sabry, M.D., Ph.D., President and Chief Executive Officer of Arete Therapeutics. "AR9281 has demonstrated an excellent safety profile and activity in multiple animal models of type 2 diabetes, and has the advantage of inhibiting a novel drug target that differentiates it from currently marketed diabetes medications. With this promising drug profile, AR9281 has the potential to provide safe and effective therapy for patients with type 2 diabetes either as monotherapy or in combination with existing treatment regimens."

The Phase IIa multicenter, double-blind, placebo-controlled study will enroll 150 pre-diabetic patients with impaired glucose tolerance, mild obesity and mild to moderate hypertension. All patients enrolled in the study will be treatment-naïve for type 2 diabetes medications. The trial will evaluate two schedules of AR9281 and placebo using a parallel design to determine the feasibility of twice-a-day dosing. Each patient will receive 28 days of treatment. Endpoints for the trial include safety, tolerability, reduction of blood pressure and various measures of glucose and lipid metabolism, with results expected in the first quarter of 2010.'/>"/>

SOURCE Arete Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. CareTech Solutions Executive to Conduct Presentation on Creating a Healthy Revenue Cycle at AHIMA Convention and Exhibit
2. Arete Therapeutics Initiates Phase 1 Clinical Trial For AR9281 as a First-in-Class Antihypertensive Agent
3. Arete Therapeutics Appoints Donald Santel to Board of Directors
4. CareTech Solutions Service Desk Equals Help Desk Plus
5. Nationally Recognized Diabetes Specialist Dr. Steven Edelman to Provide Educational Articles on Diabetes to MyCareTeam's Website Community
6. CareTech Solutions Named Best in KLAS for Extensive IT Outsourcing Services
7. EnovateIT Partners with CareTech Solutions to Create a Custom Product for Crittenton Hospital Medical Center, One of the Nation's Most Wired Hospitals
8. Prime Therapeutics Receives TIPPS Certification
9. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
10. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
11. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Starbrite Dental has recently developed a ... Six-Month Smiles is designed to give patients the straighter, ... effective way. , Many people find the idea of ... metal braces for several years, not to mention having ... braces clean, is undesirable and upsetting. , With Dr. ...
(Date:9/22/2014)... September 22, 2014 United States ... of the federal mesh lawsuits ( http://www.meshinjurylawfirm.com/lawsuits/ ) ... been consolidated for pretrial matters, issued an order ... Pelvic Repair System Products Liability Litigation (United States ... Virginia; Case no. 2:12-md-02326)—requiring that four member cases ...
(Date:9/22/2014)... Sundays are when people both exercise more and drink ... intake and physical activity , Findings differ from past ... A new Northwestern Medicine study finds that on days ... -- they drink more alcohol, too. , This is ... daily diary approach for self-reporting physical activity and alcohol ...
(Date:9/22/2014)... Teens and young adults at risk for sexually transmitted ... risky sexual behaviors, according to new recommendations from the ... 20 million new sexually transmitted infections such as gonorrhea ... involve people between 15 and 24 years old, according ... published Sept. 22 in Annals of Internal Medicine ...
(Date:9/22/2014)... Mich. A surprising new study pulls back the ... health care: differences in payment and income between physicians ... don,t. , Contrary to perception, the research indicates, ... favor surgeons and other procedure-performing doctors. , The new ... difference in pay per minute explains why doctors who ...
Breaking Medicine News(10 mins):Health News:Starbrite Dental Introduces Six-Month Smiles 2Health News:Federal Court Sets Trial Date for Boston Scientific Vaginal Mesh Cases in Florida, the Rottenstein Law Group LLP Reports 2Health News:We drink more alcohol on gym days 2Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 2Health News:Behavioral Counseling Urged for Teens, Young Adults at Risk for STDs 3Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 2Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 3Health News:Think the system for paying US doctors is rigged to favor surgeons? Study may surprise you 4
... ... worldwide operator with both CAMTS and EURAMI accreditation and Department of Defense approval, ... Birmingham, AL (PRWEB) ... it has earned full accreditation from the European Aero-Medical Institute (EURAMI). EURAMI is ...
... Nov. 9 HUYA Bioscience International, ... announced a strategic partnership with the School of ... agreement is another in a series of collaborations ... and development institutions to enable and accelerate the ...
... women ages 18 to 68 found that lubricant use during ... ratings of pleasurable and satisfying sex. Personal lubricants ... of sexual intercourse and to reduce the risk of vaginal ... use of lubricants or associated vaginal symptoms. The ...
... The American Public Health Association (APHA) applauds the ... passed last night by the House. , "With passage ... universal coverage, supporting important insurance reforms and moving our ... sick to one that focuses on keeping people healthy," ...
... pain now can take you out of the game later, ... injuries are the talk of the NFL this season, sidelining ... Parker. , Officials at the American Podiatric Medical Association and ... take care of their feet when they play fall sports ...
... ... Through Our Inner Pharmacy" by Dr. Roberto Giraldo shows that AIDS is a result of ... can be either chemical, physical, nutritional and most of all, emotional. , ... Oakland, CA (PRWEB) November 8, 2009 -- ...
Cached Medicine News:Health News:AirMed International, Top U.S. Air Ambulance, Receives EURAMI Accreditation 2Health News:HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China 2Health News:Indiana U. at APHA: Studies about why men and women use lubricants during sex 2Health News:Indiana U. at APHA: Studies about why men and women use lubricants during sex 3Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2Health News:Rx for Fall Foot Injuries 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3
(Date:9/22/2014)... , Sept. 22, 2014  For many people ... often means facing the prospect of large, painful ... imagined, regular activities are also impacted, such as ... severity of the problem, some patients even delay ... can even lead to permanent damage for some ...
(Date:9/22/2014)... , Sept. 22, 2014  CorMedix Inc. ... developing and commercializing therapeutic products for the prevention ... is pleased to announce that TUV-SUD and The ... (MEB) has granted its request for ... solution.  Neutrolin was initially approved in July 2013 ...
(Date:9/22/2014)... PLEASANTON, Calif. , Sept. 22, 2014 ... leader in device-based mechanical circulatory support therapies to save, ... D. Keith Grossman has been appointed President and ... F. Burbach , who has stepped down from his ... advisor to the company through the first quarter of ...
Breaking Medicine Technology:Phoenix Arizona Hand Doctor Develops Revolutionary New Surgery System, Eliminates Need for Large Incisions 2Neutrolin Label Expansion Approved for the European Union 2Neutrolin Label Expansion Approved for the European Union 3Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 2Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 3Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 4Thoratec Appoints D. Keith Grossman President And Chief Executive Officer 5
... Oct. 12, 2011 Endo Pharmaceuticals (Nasdaq: ENDP ... October 27, 2011 and will host a conference call and ... results.   David P. Holveck, president and CEO ... executive vice president of R&D, Alan Levin, executive vice president ...
... the results of a recent statewide survey, more than half ... their (parents,) prescription (Rx) medications, and one in seven parents ... not prescribed for their child. The survey was ... during a briefing at the Massachusetts State House hosted by ...
Cached Medicine Technology:Endo Pharmaceuticals to Announce Third Quarter 2011 Financial Results on October 27, 2011 2More Than Half of Massachusetts Parents Say Their Kids Have Access to Abusable Prescription Drugs in Their Homes 2More Than Half of Massachusetts Parents Say Their Kids Have Access to Abusable Prescription Drugs in Their Homes 3More Than Half of Massachusetts Parents Say Their Kids Have Access to Abusable Prescription Drugs in Their Homes 4
Designed for simple operation, the Model 515B pulse oximeter is ideal for use in any clinical setting; from emergency hospital transport to continuous monitoring in Anesthesia, Intensive Care and Gen...
The NPB-40 Handheld Pulse Oximeter is both compact and affordable. It is simple to operate, provides spot-check monitoring of SpO 2 and pulse rate, and is compact enough to fit in your pocket....
... Nellcor NPB-290 and NPB-295 Pulse Oximeters ... provide accuracy, reliability and proven signal ... poorly perfused patients. Equipped with Oxismart ... Technology, these pulse oximeters identify electronic ...
... the revolutionary OxiMax® Pulse Oximetry System, ... Nellcor's best-in-class pulse oximetry with the ... OxiMax N-595 Pulse Oximeter is equipped ... technology, which enables it to withstand ...
Medicine Products: